NJ: UnitedHealthcare Enteral Nutrition Criteria for Oral Specialized Formulas (Mar 2026)

UnitedHealthcare NJ updated its Enteral Nutrition policy (CS136NJ.O) effective 2026-03-01 to define explicit medical necessity criteria for oral Specialized Nutrient Formulas (Medical Foods). Coverage requires prescription by an authorized clinician or dietitian, a chronic condition with inability to meet needs by diet alone, use of a condition-specific medical food, and presence of an enumerated qualifying diagnosis (e.g., Crohn’s disease, severe malabsorption syndromes, eosinophilic esophagitis, inborn errors of metabolism, malnutrition). The policy cites evidence supporting use of exclusive/partial enteral nutrition and elemental diets for Crohn’s disease and EoE but distinguishes severe, medically necessary allergic conditions from mild food intolerances that are not covered. Readers are directed to related Benefit Considerations and a NJ durable medical equipment/supplies policy for coordination of coverage and exclusions.

This revision is identified as the UnitedHealthcare New Jersey policy CS136NJ.O for Enteral Nutrition (Oral and Tube Feeding) with an effective date of 2026-03-01. The policy text provided emphasizes updated, specific medical necessity criteria for Specialized Nutrient Formula administered orally as a primary or supplementary source of nutrition. The criteria list is explicit about prescriber types, chronicity of the condition, inability to meet nutritional needs through dietary adjustment, and the requirement that the formula be a Medical Food specially formulated for a specific condition.

The document also expands or clarifies covered clinical indications by listing a set of qualifying diagnoses (e.g., Crohn's disease, severe malabsorption syndrome, eosinophilic esophagitis, and a range of inborn errors of metabolism). The policy cross-references related benefit considerations and a separate New Jersey specific policy on durable medical equipment and supplies, indicating coordination between coverage rules for nutritional formulas and other benefit categories.

The policy defines medical necessity for orally administered specialized nutrient formulas using five explicit criteria. Coverage requires: (1) prescription by an authorized clinician (physician, advanced practitioner, or registered dietician); (2) a chronic condition expected to be prolonged or indefinite; (3) inability to achieve adequate nutrition through dietary adjustment; (4) use of a that is specially formulated for a specific condition; and (5) presence of one of the enumerated qualifying conditions. These qualifying conditions include inherited metabolic disorders, certain pediatric chronic kidney disease stages, , and several severe malabsorptive states.

The policy details specific gastrointestinal and allergic indications called out elsewhere in the clinical literature summaries. Crohn's disease is identified as a covered indication for oral specialized nutrient formulas. The policy text includes literature summaries (e.g., Zhu et al. 2023; Levine et al. 2019) that describe comparative effectiveness of exclusive enteral nutrition (EEN), partial enteral nutrition combined with the Crohn's Disease Exclusion Diet (CDED), and elemental diets in inducing and maintaining remission in pediatric and mixed-age Crohn's populations. These summaries are included within the policy to support the clinical basis for coverage of enteral formulas in Crohn's disease.

The policy also lists severe malabsorption syndrome examples (cystic fibrosis, short bowel syndrome, intestinal failure) as qualifying conditions. These are conditions commonly associated with the need for enteral supplementation and are explicitly enumerated as meeting the coverage criteria when the other medical necessity conditions are met.

The policy explicitly addresses severe food allergies, including eosinophilic esophagitis (EoE), food protein-induced allergic proctocolitis (FPIAP), and food protein-induced enterocolitis syndrome (FPIES) as covered indications when the clinical severity meets the medical necessity criteria. The document cites guideline and evidence summaries (e.g., Arias et al. 2014; Meyer et al. 2018; Hirano et al. 2020) showing high efficacy of amino acid-based elemental diets and elimination diets in inducing histologic remission in EoE and describing indications for amino-acid formulas in severe or complex pediatric food allergy presentations.

The policy distinguishes between severe, medically necessary allergic conditions and milder food allergies or intolerances: it states that mild and moderate food allergies or food intolerance can usually be treated with formulas readily available in food stores and pharmacies or with careful food selection, and that formulas for such conditions are not considered medically necessary under this policy.

The policy notes cross-references and additional considerations rather than giving exhaustive procedural details. It refers readers to a related New Jersey-specific policy on Durable Medical Equipment, Orthotics, Medical Supplies, and Repairs/Replacements for coordination of benefits and to a Benefit Considerations section for coverage limitations and exclusions. The main criteria emphasize that the formula must be a Medical Food specially formulated for a specific condition and that prescribers include clinicians and registered dietitians.

The document integrates evidence summaries (randomized trials and systematic reviews) to contextualize clinical effectiveness for covered indications (e.g., EEN/CDED in Crohn's disease and elemental diets in EoE), but the policy text itself focuses on coverage criteria rather than prescribing a single evidence-based therapeutic pathway.

OpenPayer

March 2026 Revision: UnitedHealthcare NJ Enteral Nutrition Coverage Criteria (`CS136NJ.O`)

Defined Medical Necessity Criteria and Covered Indications for Oral Specialized Nutrient Formulas

Coverage Context for `Crohn's disease` and Severe Malabsorption Syndromes

Coverage Specifics for Severe Food Allergies and `Eosinophilic Esophagitis`

Benefit Coordination, Evidence Context, and Policy Scope